...
首页> 外文期刊>The journal of immunology >Cutting Edge: miR-223 and EBV miR-BART15 Regulate the NLRP3 Inflammasome and IL-1β Production
【24h】

Cutting Edge: miR-223 and EBV miR-BART15 Regulate the NLRP3 Inflammasome and IL-1β Production

机译:前沿:miR-223和EBV miR-BART15调节NLRP3炎性小体和IL-1β的产生

获取原文
           

摘要

Although microRNA (miRNA) regulation of TLR signaling is well established, this has not yet been observed for NLR proteins or the inflammasomes they form. We have now validated a highly conserved miR-223 target site in the NLRP3 3′-untranslated region. miR-223 expression decreases as monocytes differentiate into macrophages, whereas NLRP3 protein increases during this time. However, overexpression of miR-223 prevents accumulation of NLRP3 protein and inhibits IL-1β production from the inflammasome. Virus inhibition of the inflammasome is an emerging theme, and we have also identified an EBV miRNA that can target the miR-223 binding site in the NLRP3 3′-untranslated region. Furthermore, this virus miRNA can be secreted from infected B cells via exosomes to inhibit the NLRP3 inflammasome in noninfected cells. Therefore, we have identified both the first endogenous miRNA that limits NLRP3 inflammatory capacity during myeloid cell development and also a viral miRNA that takes advantage of this, limiting inflammation for its own purposes.
机译:尽管TLR信号的microRNA(miRNA)调节机制已经确立,但对于NLR蛋白质或它们形成的炎症小体尚未见到。我们现已验证了NLRP3 3'非翻译区中高度保守的miR-223靶位点。随着单核细胞分化成巨噬细胞,miR-223表达降低,而NLRP3蛋白在此期间增加。但是,miR-223的过度表达会阻止NLRP3蛋白的积累,并抑制炎症小体产生IL-1β。对炎性体的病毒抑制是一个新兴的主题,并且我们还确定了可以靶向NLRP3 3'非翻译区中的miR-223结合位点的EBV miRNA。此外,可以通过外泌体从感染的B细胞分泌这种病毒miRNA,从而抑制未感染细胞中的NLRP3炎性体。因此,我们既鉴定了第一个在髓样细胞发育过程中限制NLRP3炎症能力的内源性miRNA,又鉴定了利用此作用,出于自身目的限制炎症的病毒miRNA。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号